Cell cycle machinery in pre-adipocytes

The cell cycle machinery in pre-adipocytes refers to the integrated network of proteins, including cyclin-dependent kinases (CDKs), cyclins, and CDK inhibitors, that regulate the proliferation of adipocyte precursor cells (Tang et al., 2003, Proc Natl Acad Sci U S A). A critical phase in the differentiation of these cells is mitotic clonal expansion (MCE), during which quiescent pre-adipocytes re-enter the cell cycle to increase the pool of cells capable of becoming mature adipocytes (Fajas, 2003, Dev Cell). Key regulators such as CDK4, CDK6, and Cyclin D1 are essential for initiating MCE, while CDK inhibitors like p21 and p27 act as checkpoints to control the rate of adipogenesis (Abella et al., 2005, Cancer Cell). In metabolic diseases like obesity, the dysregulation of this machinery leads to adipocyte hyperplasia, contributing to excessive adipose tissue expansion and subsequent insulin resistance (Luo et al., 2017, Cell Cycle). Therapeutic targeting of these components, primarily through CDK inhibitors, has been investigated as a method to limit fat mass expansion, although most current drugs in this class are approved for oncology (Malumbres & Barbacid, 2009, Nat Rev Cancer). The interaction between these cell cycle regulators and metabolic sensors like PPAR-gamma further underscores their importance in coordinating cell division with nutrient availability (Sarruf et al., 2005, Mol Cell Biol). However, the broad expression of these proteins across various tissues presents a significant challenge for drug development, as systemic inhibition can lead to adverse effects such as myelosuppression (Sherr et al., 2016, Cancer Discov).

Other names

Mitotic clonal expansion machineryAdipocyte cell cycle regulatorsPre-adipocyte proliferative machineryPre-adipocyte cell cycle machinery

Inhibition of cyclin-dependent kinases (CDKs) to arrest the cell cycle and prevent the mitotic clonal expansion phase of adipogenesis.